Valneva SE ADR (VALN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $538.42M
Last updated: Nov 17, 2026 at 4:10 PM ET
Valneva SE ADR (VALN) Statistics
Valneva SE ADR (VALN) has a market cap of $538.42M. Its share count is up 23.25% from a year earlier. It kept -110.21% of revenue as net income over the last 12 months.
Total Valuation
| Market Cap | $538.42M |
|---|---|
| Latest price (Nov 17, 2026) | $5.62 |
Key Dates
The next earnings report is expected on Nov 24, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Nov 24, 2026 (expected) |
|---|---|
| Last Earnings Date | Aug 13, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.2x and 5.8x. Its year-end P/S ranged from 1.7x to 6.9x from 2021 to 2025.
| P/S Ratio | 3.2x |
|---|---|
| P/B Ratio | 5.8x |
| P/TBV Ratio | 7.8x |
Price Statistics
The stock is down 37.90% over 52 weeks and trades 5.07% below its 50-day average.
| Beta (1Y) | 0.52 |
|---|---|
| 52-Week Change | -37.90% |
| 1-Month Change | +2.00% |
| 3-Month Change | -17.84% |
| 6-Month Change | -2.43% |
| 5-Year Change | -87.78% |
| Total Return (1Y) | -37.90% |
| Total Return (3Y CAGR) | -23.57% |
| Total Return (5Y CAGR) | -35.20% |
| Return vs SPY (1Y) | -47.62% |
| Max Drawdown (1Y) | -60.13% |
| Max Drawdown (3Y) | -70.97% |
| Sharpe Ratio (1Y) | -0.63 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $5.92 |
| 200-Day Average | $6.58 |
| 52-Week Range | $4.75 to $12.18 |
| RSI (14 Days) | 47.3 |
| Average Volume (20 Days) | 18.44K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.16x current liabilities, and total debt is 2.27x shareholder equity.
| Current Ratio | 2.16x |
|---|---|
| Quick Ratio | 1.69x |
| Debt / Equity | 2.27x |
| Interest Coverage | 0.52x |
Returns and Efficiency
Return on invested capital is -44.19% over the last 12 months, against a 5-year average of -19.80%.
| Return on Equity (ROE) | -198.75% |
|---|---|
| Return on Assets (ROA) | -41.52% |
| Return on Invested Capital (ROIC) | -44.19% |
| Return on Capital Employed (ROCE) | -40.42% |
| ROE (5Y Average) | -60.52% |
| ROA (5Y Average) | -17.08% |
| ROIC (5Y Average) | -19.80% |
| Asset Turnover | 0.33x |
| Inventory Turnover | 2.46x |
| Receivables Turnover | 10.98x |
| Cash Conversion Cycle | 132 days |
Scores
VALN has an Altman Z-Score of -2.02, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -2.02 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of EUR 143.51M over the last 12 months is down 26.90% from the 12 months before.
| Revenue | EUR 143.51M |
|---|---|
| Revenue Growth (YoY) | -26.90% |
| Gross Profit | EUR 23.47M |
| Operating Income | EUR -116.14M |
| Pretax Income | EUR -158.10M |
| Net Income | EUR -158.17M |
| EBITDA | EUR -93.22M |
| EBIT | EUR -115.12M |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 20.89% of the EUR 388.12M in total assets.
| Working Capital | EUR 119.50M |
|---|---|
| Shareholder Equity | EUR 81.09M |
| Tangible Book Value | EUR 60.18M |
| Total Assets | EUR 388.12M |
| Total Liabilities | EUR 307.03M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After EUR 2.52M of capital spending, operating cash flow left EUR -85.67M of free cash flow.
| Operating Cash Flow | EUR -83.15M |
|---|---|
| Capital Expenditures | EUR 2.52M |
| Free Cash Flow | EUR -85.67M |
| Depreciation and Amortization | EUR 21.90M |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -80.93%, against a 5-year average of -28.26%.
| Gross Margin | 16.35% |
|---|---|
| Operating Margin | -80.93% |
| Pretax Margin | -110.16% |
| Net Margin | -110.21% |
| EBITDA Margin | -64.96% |
| EBIT Margin | -80.22% |
| FCF Margin | -59.70% |
| Gross Margin (5Y Average) | 34.23% |
| Operating Margin (5Y Average) | -28.26% |
| Net Margin (5Y Average) | -39.98% |
Growth
Revenue fell 21.52% a year over 3 years.
| Revenue Growth (3Y CAGR) | -21.52% |
|---|---|
| Revenue Growth (5Y CAGR) | +9.62% |
Peer Position
Against 7 similar companies, VALN has the 4th highest P/S and the 3rd highest ROIC.
P/S RatioPeer median 3.2x
ROICPeer median -84.61%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -61.33%
| P/S Ratio | 3.2x vs 3.2x median |
|---|---|
| ROIC | -44.19% vs -84.61% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -26.90% vs -61.33% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About VALN
What is VALN's market cap?
Valneva SE ADR has a market cap of $538.42M.
How many shares of VALN are outstanding?
Valneva SE ADR has 94.82M shares outstanding. The count is up 23.25% from a year earlier.
Does VALN pay a dividend?
No. Valneva SE ADR does not pay a dividend.
VALN pages: Overview, Charting, Financials, Statistics, Valuation, Competitors